Another study on inflammatory bowel disease (ulcerative colitis) and colon cancer found that noscapine had an excellent anti-inflammatory effect that could significantly decrease the levels of proinflammatory factors such as IL-1β, IFN-γ, and IL-6, compared to the control group [26]. This evidence concerns the gene IFNG and colonic neoplasm.